ARROWHEAD PHARMACEUTICALS, INC. Earnings Per Share (Basic)
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Earnings Per Share (Basic) of -$1.36 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-04
- ARROWHEAD PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$1.36.
- ARROWHEAD PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.93, a 133.45% decline year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-12-31 was $0.22.
- ARROWHEAD PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.17.
- ARROWHEAD PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2025 was -$0.01.
- ARROWHEAD PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2024 was -$5.00.
- ARROWHEAD PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2023 was -$1.92.
- ARROWHEAD PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2022 was -$1.67.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$1.36 10-Q · filed 2026-08-04 | -$2.29 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$2.10 10-Q · filed 2026-08-04 | -$2.28 derived: net income ÷ weighted average shares · filed 2026-08-04 | |
| 2026-03-31 | -$0.93 10-Q · filed 2026-05-07 | -$0.73 10-Q · filed 2026-05-07 | -$0.90 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$2.16 derived: net income ÷ weighted average shares · filed 2026-08-04 | |
| 2025-12-31 | $0.22 10-Q · filed 2026-02-05 | $0.05 derived: net income ÷ weighted average shares · filed 2026-02-05 | -$1.22 derived: net income ÷ weighted average shares · filed 2026-08-04 | $1.48 derived: net income ÷ weighted average shares · filed 2026-08-04 | |
| 2025-09-30 | -$0.17 derived: net income ÷ weighted average shares · filed 2025-11-25 | -$1.44 derived: net income ÷ weighted average shares · filed 2026-08-04 | $1.25 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$0.01 10-K · filed 2025-11-25 | |
| 2025-06-30 | -$1.26 10-Q · filed 2026-08-04 | $1.43 derived: net income ÷ weighted average shares · filed 2026-08-04 | $0.17 10-Q · filed 2026-08-04 | -$1.14 derived: net income ÷ weighted average shares · filed 2026-08-04 | |
| 2025-03-31 | $2.78 10-Q · filed 2026-05-07 | $1.53 10-Q · filed 2026-05-07 | $0.21 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$1.14 derived: net income ÷ weighted average shares · filed 2026-05-07 | |
| 2024-12-31 | -$1.39 10-Q · filed 2026-02-05 | -$2.76 derived: net income ÷ weighted average shares · filed 2026-02-05 | -$4.13 derived: net income ÷ weighted average shares · filed 2026-02-05 | -$5.15 derived: net income ÷ weighted average shares · filed 2026-02-05 | |
| 2024-09-30 | -$1.37 derived: net income ÷ weighted average shares · filed 2025-11-25 | -$2.75 derived: net income ÷ weighted average shares · filed 2025-11-25 | -$3.76 derived: net income ÷ weighted average shares · filed 2025-11-25 | -$5.00 10-K · filed 2025-11-25 | |
| 2024-06-30 | -$1.38 10-Q · filed 2025-08-07 | -$2.39 derived: net income ÷ weighted average shares · filed 2025-08-07 | -$3.63 10-Q · filed 2025-08-07 | -$4.66 derived: net income ÷ weighted average shares · filed 2025-11-25 | |
| 2024-03-31 | -$1.02 10-Q · filed 2025-05-12 | -$2.24 10-Q · filed 2025-05-12 | -$3.27 derived: net income ÷ weighted average shares · filed 2025-11-25 | -$4.23 derived: net income ÷ weighted average shares · filed 2025-11-25 | |
| 2023-12-31 | -$1.24 10-Q · filed 2025-02-10 | -$2.26 derived: net income ÷ weighted average shares · filed 2025-11-25 | -$3.22 derived: net income ÷ weighted average shares · filed 2025-11-25 | -$2.77 derived: net income ÷ weighted average shares · filed 2025-11-25 | |
| 2023-09-30 | -$1.02 derived: net income ÷ weighted average shares · filed 2025-11-25 | -$1.99 derived: net income ÷ weighted average shares · filed 2025-11-25 | -$1.53 derived: net income ÷ weighted average shares · filed 2025-11-25 | -$1.92 10-K · filed 2025-11-25 | |
| 2023-06-30 | -$0.96 10-Q · filed 2024-08-08 | -$0.51 derived: net income ÷ weighted average shares · filed 2024-08-08 | -$0.90 10-Q · filed 2024-08-08 | -$1.70 derived: net income ÷ weighted average shares · filed 2024-11-26 | |
| 2023-03-31 | $0.46 10-Q · filed 2024-05-09 | $0.07 10-Q · filed 2024-05-09 | -$0.74 derived: net income ÷ weighted average shares · filed 2024-11-26 | -$1.42 derived: net income ÷ weighted average shares · filed 2024-11-26 | |
| 2022-12-31 | -$0.39 10-Q · filed 2024-02-06 | -$1.20 derived: net income ÷ weighted average shares · filed 2024-11-26 | -$1.88 derived: net income ÷ weighted average shares · filed 2024-11-26 | -$1.46 derived: net income ÷ weighted average shares · filed 2024-11-26 | |
| 2022-09-30 | -$0.81 derived: net income ÷ weighted average shares · filed 2024-11-26 | -$1.49 derived: net income ÷ weighted average shares · filed 2024-11-26 | -$1.07 derived: net income ÷ weighted average shares · filed 2024-11-26 | -$1.67 10-K · filed 2024-11-26 | |
| 2022-06-30 | -$0.68 10-Q · filed 2023-08-07 | -$0.26 derived: net income ÷ weighted average shares · filed 2023-08-07 | -$0.86 10-Q · filed 2023-08-07 | -$1.47 derived: net income ÷ weighted average shares · filed 2023-11-29 | |
| 2022-03-31 | $0.42 10-Q · filed 2023-05-02 | -$0.18 10-Q · filed 2023-05-02 | -$0.78 derived: net income ÷ weighted average shares · filed 2023-11-29 | -$1.07 derived: net income ÷ weighted average shares · filed 2023-11-29 | |
| 2021-12-31 | -$0.60 10-Q · filed 2023-02-06 | -$1.21 derived: net income ÷ weighted average shares · filed 2023-11-29 | -$1.50 derived: net income ÷ weighted average shares · filed 2023-11-29 | -$1.76 derived: net income ÷ weighted average shares · filed 2023-11-29 | |
| 2021-09-30 | -$0.61 derived: net income ÷ weighted average shares · filed 2023-11-29 | -$0.90 derived: net income ÷ weighted average shares · filed 2023-11-29 | -$1.15 derived: net income ÷ weighted average shares · filed 2023-11-29 | -$1.36 10-K · filed 2023-11-29 | |
| 2021-06-30 | -$0.29 10-Q · filed 2022-08-04 | -$0.55 derived: net income ÷ weighted average shares · filed 2022-08-04 | -$0.75 10-Q · filed 2022-08-04 | -$1.22 derived: net income ÷ weighted average shares · filed 2022-11-28 | |
| 2021-03-31 | -$0.26 10-Q · filed 2022-05-10 | -$0.46 10-Q · filed 2022-05-10 | -$0.93 derived: net income ÷ weighted average shares · filed 2022-11-28 | -$1.07 derived: net income ÷ weighted average shares · filed 2022-11-28 | |
| 2020-12-31 | -$0.20 10-Q · filed 2022-02-02 | -$0.67 derived: net income ÷ weighted average shares · filed 2022-11-28 | -$0.81 derived: net income ÷ weighted average shares · filed 2022-11-28 | -$1.00 derived: net income ÷ weighted average shares · filed 2022-11-28 | |
| 2020-09-30 | -$0.48 10-K · filed 2020-11-23 | -$0.61 derived: net income ÷ weighted average shares · filed 2022-11-28 | -$0.80 derived: net income ÷ weighted average shares · filed 2022-11-28 | -$0.84 10-K · filed 2022-11-28 | |
| 2020-06-30 | -$0.13 10-Q · filed 2021-08-05 | -$0.33 derived: net income ÷ weighted average shares · filed 2021-08-05 | -$0.36 10-Q · filed 2021-08-05 | -$0.25 derived: net income ÷ weighted average shares · filed 2021-11-22 | |
| 2020-03-31 | -$0.20 10-Q · filed 2021-05-04 | -$0.23 10-Q · filed 2021-05-04 | -$0.11 derived: net income ÷ weighted average shares · filed 2021-11-22 | $0.10 derived: net income ÷ weighted average shares · filed 2021-11-22 | |
| 2019-12-31 | -$0.03 10-Q · filed 2021-02-04 | $0.09 derived: net income ÷ weighted average shares · filed 2021-11-22 | $0.31 derived: net income ÷ weighted average shares · filed 2021-11-22 | $0.56 derived: net income ÷ weighted average shares · filed 2021-11-22 | |
| 2019-09-30 | $0.12 10-K · filed 2020-11-23 | $0.34 derived: net income ÷ weighted average shares · filed 2021-11-22 | $0.59 derived: net income ÷ weighted average shares · filed 2021-11-22 | $0.72 10-K · filed 2021-11-22 | |
| 2019-06-30 | $0.21 10-K · filed 2020-11-23 | $0.47 derived: net income ÷ weighted average shares · filed 2020-08-05 | $0.60 10-Q · filed 2020-08-05 | $0.49 derived: net income ÷ weighted average shares · filed 2020-11-23 | |
| 2019-03-31 | $0.25 10-K · filed 2020-11-23 | $0.39 10-Q · filed 2020-05-07 | $0.28 derived: net income ÷ weighted average shares · filed 2020-11-23 | $0.11 derived: net income ÷ weighted average shares · filed 2020-11-23 | |
| 2018-12-31 | $0.13 10-K · filed 2020-11-23 | $0.01 derived: net income ÷ weighted average shares · filed 2020-11-23 | -$0.16 derived: net income ÷ weighted average shares · filed 2020-11-23 | -$0.33 derived: net income ÷ weighted average shares · filed 2020-11-23 | |
| 2018-09-30 | -$0.12 10-K · filed 2019-11-25 | -$0.30 derived: net income ÷ weighted average shares · filed 2020-11-23 | -$0.48 derived: net income ÷ weighted average shares · filed 2020-11-23 | -$0.65 10-K · filed 2020-11-23 | |
| 2018-06-30 | -$0.18 10-K · filed 2019-11-25 | -$0.36 derived: net income ÷ weighted average shares · filed 2019-08-05 | -$0.53 10-Q · filed 2019-08-05 | ||
| 2018-03-31 | -$0.18 10-K · filed 2019-11-25 | -$0.35 10-Q · filed 2019-05-08 | |||
| 2017-12-31 | -$0.18 10-K · filed 2019-11-25 | ||||
| 2017-09-30 | -$0.47 10-K · filed 2019-11-25 | ||||
| 2013-03-31 | -$0.41 10-Q · filed 2013-05-09 | -$0.74 10-Q · filed 2013-05-09 | |||
| 2012-12-31 | -$0.33 10-Q · filed 2013-02-13 | ||||
| 2012-09-30 | -$0.43 derived: net income ÷ weighted average shares · filed 2014-11-25 | -$1.12 derived: net income ÷ weighted average shares · filed 2014-11-25 | -$1.63 derived: net income ÷ weighted average shares · filed 2014-11-25 | -$1.90 10-K · filed 2012-12-28 | |
| 2012-06-30 | -$0.71 10-Q · filed 2012-08-13 | -$1.22 derived: net income ÷ weighted average shares · filed 2013-08-07 | -$1.48 10-Q · filed 2012-08-13 | ||
| 2012-03-31 | -$0.50 10-Q · filed 2013-05-09 | -$0.75 10-Q · filed 2013-05-09 | |||
| 2011-12-31 | -$0.25 10-Q · filed 2013-02-13 | ||||
| 2011-09-30 | -$0.39 derived: net income ÷ weighted average shares · filed 2012-12-28 | -$0.64 derived: net income ÷ weighted average shares · filed 2012-12-28 | -$0.24 derived: net income ÷ weighted average shares · filed 2012-12-28 | -$0.44 10-K · filed 2012-12-28 | |
| 2011-06-30 | -$0.25 10-Q · filed 2012-08-13 | -$0.03 10-Q · filed 2011-08-08 | $0.15 derived: net income ÷ weighted average shares · filed 2012-08-13 | -$0.05 10-Q · filed 2012-08-13 | |
| 2011-03-31 | $0.40 10-Q · filed 2012-05-08 | $0.20 10-Q · filed 2012-05-08 | |||
| 2010-09-30 | $0.01 derived: net income ÷ weighted average shares · filed 2011-12-20 | $0.05 derived: net income ÷ weighted average shares · filed 2011-12-20 | -$0.90 10-K · filed 2011-12-20 | ||
| 2010-06-30 | -$0.01 10-Q · filed 2011-08-08 | -$0.06 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |